Crossmark

A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies

Crossref DOI link: https://doi.org/10.1007/s00296-020-04643-z

Published Online: 2020-07-17

Published Print: 2020-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gkoutzourelas, Athanasios https://orcid.org/0000-0002-4775-0410
Liaskos, Christos https://orcid.org/0000-0001-8343-3810
Simopoulou, Theodora https://orcid.org/0000-0003-2604-5090
Katsiari, Christina https://orcid.org/0000-0002-4174-6576
Efthymiou, George https://orcid.org/0000-0002-8706-1193
Scheper, Thomas https://orcid.org/0000-0002-2344-3854
Meyer, Wolfgang https://orcid.org/0000-0001-8973-4550
Tsirogianni, Alexandra https://orcid.org/0000-0003-2531-4113
Tsigalou, Christina https://orcid.org/0000-0002-7869-6824
Dardiotis, Efthymios https://orcid.org/0000-0003-2957-641X
Daoussis, Dimitrios https://orcid.org/0000-0001-8027-3655
Sakkas, Lazaros I. https://orcid.org/0000-0002-7670-3314
Bogdanos, Dimitrios P. https://orcid.org/0000-0002-9697-7902
License Information

Text and Data Mining valid from 2020-07-17

Version of Record valid from 2020-07-17
More Information

Article History

Received: 11 January 2020

Accepted: 3 July 2020

First Online: 17 July 2020

Compliance with ethical standards

:

: T. Scheper and W. Meyer are employees of Euroimmun; all other authors do not have anything to disclose.